6.631.34% ( -0.09 )
Delay Trading: Nov 16, 09:48:18Valuation
Current ValuationThe current P/E ratio is -39.65, within the reasonable range, cheaper than 65.3% of the time in the past 3 years, and the industry ranks 4/7, the industry Median -39.65.
-39.65xP/E
¥6.72Stock price
¥-0.17Earnings per share
-39.65xP/E
Stock price¥6.72Earnings per share¥-0.17
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 30.53x
- Typical range
- -58.08x–120.86x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
0157314471628
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
300253SZWinning Health | -39.65x | 114.78% | ¥14.79B |
300451SZB-SOFT | -8.76x | 111.54% | ¥5.17B |
300550SZHeren Health | -124.71x | -- | ¥3.50B |
300288SZLongmaster Info-tech | -336.08x | -- | ¥3.11B |
301337SZYarward | -197.81x | -- | ¥2.57B |
688246SHGOODWILL | -9.76x | 61.41% | ¥1.94B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
